Services may be impacted in response to COVID-19. Please contact organizations listed here prior to visiting in person to receive the most current service information and any vaccination requirements that may be in place.

MitoCanada Foundation

Site: Mailing Address

Contact Information
Office Phone Toll free 1-877-708-6486
Social Media Facebook Facebook:
Instagram Instagram:
LinkedIn LinkedIn:
Twitter Twitter:
YouTube YouTube:
Primary Contact Catherine Mulvale, Chief Development Officer; Phone: 416-886-6777; Email:
Contact Form
Agency Information
Description (Agency) A registered charity that provides support and awareness to Canadians affected by mitochondrial disease.
Legal Status (50) Non Profit
Established 2010
Primary Executive Kate Murray, Chief Executive Officer and President; Phone: 905-599-1927; Email:
Funding Grants ; Fundraising - Sponsorships ; Donations
Description and Service Details
Description (Service) Provides information, education and support to those living with mitochondrial disease
  • creating communities where those impacted by mitochondrial dysfunction feel empowered, inspired 
    and connected 
  • support education and awareness 
  • advocate for those living with or at risk of developing mitochondrial disease 
  • fund research that is patient focused and transformational
Hours Not specified
Areas Served Canada
Eligibility People with mitochondrial disease, their families and caregivers
Application Contact for information
Languages English
Fees None
Site Information
Located In Community Oakville
Address & Map
Oakville, ON
View Google Map
Mailing Address c/o MitoCanada Foundation 
PO Box 30052 
478 Dundas St W 
Oakville, ON L6H 7L8
Physical Access Not Applicable - mailing address
Categories and Classification
Service Categories Disease/Disability Information ~ Mitochondrial Diseases ; Health Related Advocacy Groups ~ Mitochondrial Diseases ; Health/Disability Related Support Groups ~ Mitochondrial Diseases

Any omissions are unintentional and HIP disclaims any liability for unauthorized use or reproduction of any portion of this site. For a complete copyright and license statement please refer to our Terms of Use.